23 October 2026 POLYCYSTIC KIDNEY DISEASE PROGRAM – AMERICAN SOCIETY OF NEPHROLOGY PRESENTATION • PYC is a precision medicine company dedicated to changing the lives of patients with genetic diseases who have no treatment options available • The Company is progressing a drug candidate (known...
PKD Program - ASN Presentation
Filed with ASX · · 14 pages · English
Release
PYC Therapeutics Limited on 6ix
In the deck
Earlier from PYC Therapeutics
- Exercise of Options and Cleansing Notice
- Notice of Annual General Meeting/Proxy Form
- Application for quotation of securities - PYC
- Notification of cessation of securities - PYC
- PKD Program - Presentation of Data at ASN Conference
Later from PYC Therapeutics
- Quarterly Activities/Appendix 4C Cash Flow Report
- Change of Director's Interest Notice
- Annual General Meeting - Conference Link
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics